12:00 AM
Aug 05, 2013
 |  BC Week In Review  |  Company News  |  Deals

Bristol-Myers, Samsung BioLogics deal

Contract manufacturer Samsung BioLogics will manufacture Bristol-Myers' Yervoy ipilimumab at a plant in Songdo Incheon, South Korea, under a 10-year...

Read the full 90 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >